Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
OLEX	STARTED	Idalopirdine 60 mg	1,463
OLEX	STARTED	Idalopirdine 60 mg + Memantine	0
OLEX	COMPLETED	Idalopirdine 60 mg	1,235
OLEX	COMPLETED	Idalopirdine 60 mg + Memantine	0
OLEX	NOT COMPLETED	Idalopirdine 60 mg	228
OLEX	NOT COMPLETED	Idalopirdine 60 mg + Memantine	0
OLEX-MEM	STARTED	Idalopirdine 60 mg	0
OLEX-MEM	STARTED	Idalopirdine 60 mg + Memantine	101
OLEX-MEM	COMPLETED	Idalopirdine 60 mg	0
OLEX-MEM	COMPLETED	Idalopirdine 60 mg + Memantine	82
OLEX-MEM	NOT COMPLETED	Idalopirdine 60 mg	0
OLEX-MEM	NOT COMPLETED	Idalopirdine 60 mg + Memantine	19

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02079246/flow